Allergic reaction to anisakis-contaminated fish after the first administration of BNT162b2 mRNA vaccine: A case report

Abstract

SARS-CoV-2 vaccination is an effective means to prevent severe illness and death due to SARS-CoV-2 infection [1]. Vaccine safety has been carefully monitored to be sure that the benefit outweighs the risk of adverse events (AEs). Common AEs of the BNT162b2 mRNA vaccine, for example, include fatigue (45%), headache (40%), and chills (28%) after the first administration in accordance with the adult phase III clinical trial [1].